Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine.

[1]  Y. Cheng,et al.  Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity. , 1978, Journal of medicinal chemistry.

[2]  F. Schabel,et al.  Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine , 1977 .

[3]  S. Lee,et al.  Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia. , 1977, Cancer research.

[4]  G. Lepage,et al.  Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. , 1976, Cancer research.

[5]  C. Cass,et al.  Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin. , 1976, Cancer research.

[6]  R. Buchanan,et al.  CLINICAL APPLICATION OF ADENINE ARABINOSIDE * , 1975, Annals of the New York Academy of Sciences.

[7]  W. Plunkett,et al.  Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. , 1975, Cancer research.

[8]  P. W. Woo,et al.  A novel adenosine and ara‐a deaminase inhibitor, (R)‐3‐(2‐deoxy‐β‐D‐erythro‐pentofuranosyl)‐3,6,7,8‐tetrahydroimidazo[4,5 ‐d] [1,3]diazepin‐8‐ol , 1974 .

[9]  H. Schaeffer,et al.  Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. , 1974, Journal of medicinal chemistry.

[10]  A. Khaliq,et al.  Studies of 9-beta-D-arabinofuranosyladenine in man. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[11]  B. E. Evans,et al.  [A potential transition state analog for adenosine deaminase]. , 1970, Journal of the American Chemical Society.

[12]  R. Koshiura,et al.  Some Inhibitors of Deamination of 9-β-d-Arabinofuranosyladenine and 9-β-d-Xylofuranosyladenine by Blood and Neoplasms of Experimental Animals and Humans , 1968 .

[13]  J. York,et al.  A proposed mechanism for the action of 9-beta-D-arabinofuranosyladenine as an inhibitor of the growth of some ascites cells. , 1966, Canadian journal of biochemistry.

[14]  J. Brink,et al.  9-BETA-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS. , 1965, Canadian journal of biochemistry.

[15]  J. Brink,et al.  METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES. , 1964, Cancer research.

[16]  J. Montgomery,et al.  SYNTHESIS OF POTENTIAL ANTICANCER AGENTS. X. 2-FLUOROADENOSINE1 , 1957 .